Abstract:Hepatocarcinogenesis is a stepwise process during which multiple genes are altered. Understanding the molecular mechanisms that induce hepatocarcinogenesis may improve the screening, prevention and treatment of patients with hepatocellular carcinoma (HCC). In recent years, the oxidored-nitro domain-containing protein 1 (NOR1) gene has been identified to have an important role in the development of HCC in vitro experiments. The current study aimed to examine the expression of NOR1 mRNA and protein expression in specimens of normal liver, hepatitis, cirrhosis and HCC, together representing the process of HCC development. Furthermore, the association between NOR1 expression and clinicopathological parameters of HCC patients was analyzed. Tissue microarrays containing the specimens of human normal liver, hepatitis, cirrhosis and HCC were purchased, and in situ hybridization and immunohistochemistry were used to detect the expression of NOR1 mRNA and protein expression, respectively. It was revealed that the positive rate of NOR1 protein and mRNA expression in the specimens of hepatitis and cirrhosis were not significantly different from that in the normal liver samples. However, the specimens of HCC exhibited an increased positive rate of NOR1 protein and mRNA expression in comparison with the normal liver samples. In addition, a higher positive rate of NOR1 protein expression was observed in HCC patients with a poor pathological differentiation grade and high tumor node metastasis (TNM) stage. In conclusion, the present study provides evidence, for the first time, of the increased expression of NOR1 in human HCC tissues, and its correlation with the pathological stage and TNM status. These findings indicate that NOR1 may be involved in the progression of HCC and it could be employed as a predictive biomarker in HCC development.

Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways.

Tumor suppressor gene Oxidored-nitro domain-containing protein 1 regulates nasopharyngeal cancer cell autophagy, metabolism, and apoptosis in vitro.

Preparation of Polyclonal Antibody Specific for NOR1 and Detection of Its Expression Pattern in Human Tissues and Nasopharyngeal Carcinoma

Expression of oxidored nitro domain-containing protein 1(NOR1) impairs nasopharyngeal carcinoma cells adaptation to hypoxia and inhibits PDK1 expression

The Tumor Suppressor NOR1 Suppresses Cell Growth, Invasiveness, and Tumorigenicity in Glioma.

Oxidored-nitro Domain Containing Protein 1 (NOR1) Expression Suppresses Slug/vimentin but Not Snail in Nasopharyngeal Carcinoma: Inhibition of EMT in Vitro and in Vivo in Mice.

The NOR1/OSCP1 proteins in cancer: From epigenetic silencing to functional characterization of a novel tumor suppressor

Screen and Identification of the Protein-Protein Interactors of Nor1, A Novel Gene Down-Regulated in Nasopharyngeal Carcinoma

NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma.

NOR1 Regulates Morphogenetic Cell Behavior in vitro Coincident With Inhibition of a Non-canonical Wnt-signaling Cascade

Cloning, expression, and mutation analysis of NOR 1 , a novel human gene down-regulated in HNE 1 nasopharyngeal carcinoma cell line

Studies of association between nasopharyngeal carcinoma and single-nucleotide polymorphisms in NOR1, a novel oxidored-nitro domain-containing protein gene

Nor1 Suppresses Cancer Stem-Like Cells Properties Of Tumor Cells Via The Inhibition Of The Akt-Gsk-3 Beta-Wnt/Beta-Catenin-Aldh1a1 Signal Circuit

Oxidored-nitro Domain-Containing Protein 1 Expression is Associated with the Progression of Hepatocellular Carcinoma

NOR1 enhaced 5516376in HepG2 is dependent on Grb2 mediated MAPK pathway

Inhibition of Grb2-mediated activation of MAPK signal transduction suppresses NOR 1/CB1954-induced cytotoxicity in the HepG2 cell line

Differential expression of oxidored nitro domain containing protein 1 (NOR1), in mouse tissues and in normal and cancerous human tissues.

NOR1 Enhanced CB1954 Induced Cell Cytotoxicity in HepG2 is Dependent on Grb2 Mediated MAPK Pathway

Effect of NOR1 gene knockdown on the biological behavior of HeLa cells]

Abberent Expression of NOR1 Protein in Tumor Associated Macrophages Contributes to the Development of DEN-induced Hepatocellular Carcinoma.

Changes in global gene expression induced by NOR1 over-expression in HepG2 cells